Cargando…
The association between immunosuppressant and the outcome of COVID-19
We read with great interest the study investigating the association between immunosuppressant and the outcome of patients withs SARS-CoV-2 infection [1]. They found that the prior use of immunosuppressant would be associated with a significantly increased risk of death (adjusted relative risk [RR],...
Autores principales: | Hsu, Chi-Kuei, Lai, Chih-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248176/ https://www.ncbi.nlm.nih.gov/pubmed/35777768 http://dx.doi.org/10.1183/13993003.00816-2022 |
Ejemplares similares
-
Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma
por: Hsu, Chi-Kuei, et al.
Publicado: (2022) -
Inhaled ciclesonide for outpatients with COVID-19: A meta-analysis
por: Hsu, Chi-Kuei, et al.
Publicado: (2022) -
COVID-19 associated with concomitant mucormycosis and aspergillosis
por: Lai, Chih-Cheng, et al.
Publicado: (2022) -
The true effect of traditional Chinese medicine on the clinical outcome of hospitalized patients with COVID-19?
por: Hsu, Chi-Kuei, et al.
Publicado: (2022) -
Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
por: Ritchie, Andrew I, et al.
Publicado: (2020)